TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2020

Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells.

Ana Cordeiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.